Dr Antoine Hollebecque
- Spécialité
- Oncologue médical, expert colon, estomac, foie et pancréas
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis. (9 avr. 2025)
- Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry. (1 avr. 2025)
- Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. (1 mars 2025)
- New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe. (19 févr. 2025)
- Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer. (6 févr. 2025)